Mirati Therapeutics (MRTX) Prices 3.45M Share Offering at $145/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/13/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. QQQ
9. TENB
10. SPCX

Go back to Mirati Therapeutics (MRTX) Prices 3.45M Share Offering at $145/sh

Mirati Therapeutics (MRTX) Announces Proposed $500M Share Offering

November 9, 2021 4:24 PM EST

Mirati Therapeutics, Inc. (Nasdaq: MRTX) a clinical-stage oncology company, today announced that it intends to offer and sell in an underwritten public offering $500 million of shares of its common stock. In addition, Mirati expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the total shares offered in the public offering at the public offering price, less the underwriting discounts and commissions. The offering is subject to market and other conditions,... More

Mirati Therapeutics (MRTX) PT Raised to $235 at Stifel

November 9, 2021 7:13 AM EST

Stifel analyst Ben Burnett raised the price target on Mirati Therapeutics (NASDAQ: MRTX) to $235.00 (from $202.00) while maintaining a Buy rating.

The analyst commented, "Were reiterating our Buy-rating following initial pembro+adagrasib frontline NSCLC data disclosed in conjunction with the company's 3Q21 update. The... More

Mirati Therapeutics (MRTX ) PT Raised to $175 at Morgan Stanley

November 9, 2021 3:17 AM EST

Morgan Stanley analyst Michael Ulz raised the price target on Mirati Therapeutics (NASDAQ: MRTX ) to $175.00 (from $173.00) while maintaining a Equalweight rating.... More